Compound Detail
CHEMBL4215895
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4215895 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FPEOWZPHZJGGSE-RBPBNGIGSA-N |
2
Targets
7
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
464.5
MW (Da)
4.94
ALogP
4
HBA
0
HBD
49.3
PSA (Ų)
0.40
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 6.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| BV-2 CHEMBL614781 | IC50 | 6.3 | 5.96 | 500.0 | 6 |
| Amyloid-beta precursor protein CHEMBL2487 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| BV-2 | IC50 | = | 500.0 | nM | 6.3 | Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-... | 29499485 |
| BV-2 | IC50 | = | 500.0 | nM | 6.3 | Antiinflammatory activity in LPS-stimulated mouse BV-2 cells assessed as inhibit... | 35931005 |
| BV-2 | IC50 | = | 1000.0 | nM | 6.0 | Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-... | 29499485 |
| BV-2 | IC50 | = | 1000.0 | nM | 6.0 | Antiinflammatory activity in LPS-stimulated mouse BV-2 cells assessed as inhibit... | 35931005 |
| BV-2 | IC50 | = | 2600.0 | nM | 5.58 | Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-... | 29499485 |
| BV-2 | IC50 | = | 2600.0 | nM | 5.58 | Antiinflammatory activity in LPS-stimulated mouse BV-2 cells assessed as inhibit... | 35931005 |
| Amyloid-beta precursor protein | IC50 | = | 5000.0 | nM | 5.3 | Inhibition of Amyloid-beta (unknown origin) (1 to 42 residues) | 37722288 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29499485 | 10.1016/j.ejmech.2018.02.063 | BV-2 | 4 |
| 35931005 | 10.1016/j.ejmech.2022.114597 | BV-2 | 3 |
| 29499485 | 10.1016/j.ejmech.2018.02.063 | No relevant target | 1 |
| 29499485 | 10.1016/j.ejmech.2018.02.063 | NF-kappa-B inhibitor alpha | 1 |
| 29499485 | 10.1016/j.ejmech.2018.02.063 | Transcription factor p65 | 1 |
| 29499485 | 10.1016/j.ejmech.2018.02.063 | Mitogen-activated protein kinase 1 and 3 (ERK2 and ERK1) | 1 |
| 29499485 | 10.1016/j.ejmech.2018.02.063 | Unchecked | 1 |
| 29499485 | 10.1016/j.ejmech.2018.02.063 | MAP kinase p38 | 1 |
| 37722288 | 10.1016/j.ejmech.2023.115817 | Unchecked | 1 |
| 37722288 | 10.1016/j.ejmech.2023.115817 | Amyloid-beta precursor protein | 1 |
Data from ChEMBL 36 via Core Engine